President, CEO and Executive Dean, Baylor College of Medicine
Dr. Paul Klotman began serving as president, CEO and Executive Dean of Baylor College of Medicine on Sept. 1, 2010. He received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his medicine and nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member before moving to the National Institutes of Health in 1988, where he became chief of the Molecular Medicine Section in the Laboratory of Developmental Biology. In 1993, he became chief of the Viral Pathogenesis Laboratory in the NIDR/NIH. In 1994, he moved to Mount Sinai School of Medicine as Chief of the Division of Nephrology. In 2001, he was selected to be the chair of the Samuel Bronfman Department of Medicine of the Mount Sinai School of Medicine.
Dr. Klotman's research has been a blend of both basic and clinical research in molecular virology and AIDS pathogenesis. He is the author of more than 200 publications, and he has been a visiting professor and lecturer internationally in the field of HIV pathogenesis. He has been elected to both the American Society of Clinical Investigation and the Association of American Physicians. He is on the editorial boards of journals both in the United States and in Europe, and he has served on and chaired numerous study sections including those from the NIH, the American Heart Association, the National Kidney Foundation, and the VA research service.
In addition to his laboratory efforts, Dr. Klotman has been an active clinician, teacher, and mentor. Students from his laboratory have won prestigious scientific competitions. He has trained over 50 clinical fellows, postdoctoral fellows, and students in his laboratory since 1984, most of whom are independently funded. His mentees now include several Deans and many Chairs, Division Chiefs and Center Directors.
Dr. Klotman serves on the scientific advisory boards of biotech, pharmaceutical, and health care companies. He also serves on the board of several companies including those with interests in natural resources and conservation.
At Baylor College of Medicine, he oversees the only private health sciences university in the Greater Southwest United States, with total research funding of more than $500 million. The medical school is ranked among the top 25 institutions for research and the top 5 for primary care by U.S. News & World Report. The School of Health Professions is among the best in the nation as is the Graduate School of Biomedical Sciences. As the CEO of Baylor College of Medicine, he oversees approximately 15,000 employees, 3,500 students, residents and fellows, and is responsible for the Baylor medical staff at Baylor St. Luke’s Medical Center, Texas Children’s Hospital, the DeBakey VA Medical Center, Ben Taub Hospital and its affiliated clinics, the Menninger Clinic and the Children’s Hospital of San Antonio. He serves on the Board of Directors of St. Luke’s Health System and the Baylor St. Luke’s Medical Center, the College’s jointly owned and governed private adult hospital. The enterprise revenue is over $2 billion dollars with net assets of approximately $2 billion.